These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 33536348)
41. Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer. Lin K; Huang J; Luo H; Luo C; Zhu X; Bu F; Xiao H; Xiao L; Zhu Z Aging (Albany NY); 2020 Mar; 12(7):5832-5857. PubMed ID: 32235004 [TBL] [Abstract][Full Text] [Related]
42. A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer. Xu K; He J; Zhang J; Liu T; Yang F; Ren T Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33034614 [TBL] [Abstract][Full Text] [Related]
43. Qu S; Liu J; Wang H Front Immunol; 2021; 12():648416. PubMed ID: 33889156 [TBL] [Abstract][Full Text] [Related]
44. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer. Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544 [TBL] [Abstract][Full Text] [Related]
45. Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO. Wen S; Peng W; Chen Y; Du X; Xia J; Shen B; Zhou G BMC Cancer; 2022 Feb; 22(1):193. PubMed ID: 35184748 [TBL] [Abstract][Full Text] [Related]
46. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma. Shen R; Liu B; Li X; Yu T; Xu K; Ma J BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781 [TBL] [Abstract][Full Text] [Related]
47. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer. Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239 [TBL] [Abstract][Full Text] [Related]
48. Identification of a novel immune microenvironment signature predicting survival and therapeutic options for bladder cancer. Yan Y; Huang Z; Cai J; Tang P; Zhang F; Tan M; Shen B Aging (Albany NY); 2020 Dec; 13(2):2780-2802. PubMed ID: 33408272 [TBL] [Abstract][Full Text] [Related]
49. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers. Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L Front Immunol; 2019; 10():6. PubMed ID: 30761122 [No Abstract] [Full Text] [Related]
50. Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients. Xiao Z; Nie K; Han T; Cheng L; Zhang Z; Peng W; Shi D J Immunol Res; 2021; 2021():6439975. PubMed ID: 34541005 [TBL] [Abstract][Full Text] [Related]
51. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer. Yang C; Cao F; Huang S; Zheng Y Front Immunol; 2021; 12():717505. PubMed ID: 34335633 [TBL] [Abstract][Full Text] [Related]
52. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer. Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485 [TBL] [Abstract][Full Text] [Related]
53. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma. Lei S; Zhang Y Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166 [TBL] [Abstract][Full Text] [Related]
54. Development and validation of an immune-related prognostic signature in lung adenocarcinoma. Sun S; Guo W; Wang Z; Wang X; Zhang G; Zhang H; Li R; Gao Y; Qiu B; Tan F; Gao Y; Xue Q; Gao S; He J Cancer Med; 2020 Aug; 9(16):5960-5975. PubMed ID: 32592319 [TBL] [Abstract][Full Text] [Related]
55. Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma. Chen B; Deng T; Deng L; Yu H; He B; Chen K; Zheng C; Wang D; Wang Y; Chen G BMC Cancer; 2021 Nov; 21(1):1211. PubMed ID: 34772375 [TBL] [Abstract][Full Text] [Related]
56. Integrated single-cell and bulk RNA-seq analysis identifies a prognostic T-cell signature in colorectal cancer. Cui P; Wang H; Bai Z Sci Rep; 2024 Aug; 14(1):20177. PubMed ID: 39215032 [TBL] [Abstract][Full Text] [Related]
57. Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer. Luo Y; Chen L; Zhou Q; Xiong Y; Wang G; Liu X; Xiao Y; Ju L; Wang X J Cell Mol Med; 2020 Nov; 24(22):13370-13382. PubMed ID: 33048468 [TBL] [Abstract][Full Text] [Related]
58. An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning. Ren EH; Deng YJ; Yuan WH; Wu ZL; Zhang GZ; Xie QQ J Cancer Res Clin Oncol; 2021 Jan; 147(1):153-165. PubMed ID: 32968877 [TBL] [Abstract][Full Text] [Related]
59. Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients. Ke J; Liu XH; Jiang XF; He Z; Xiao J; Zheng B; Chen YF; Cai ZR; Zheng XB; Zou YF; Lan P; Wu XJ; Gao F Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e62-e70. PubMed ID: 32863096 [TBL] [Abstract][Full Text] [Related]
60. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer. Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]